FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046455110> ?p ?o ?g. }

• W2046455110 endingPage "1896" @default.
• W2046455110 startingPage "1890" @default.
• W2046455110 abstract "Transplantation-related mortality (TRM) is high after HLA-mismatched umbilical cord blood (UCB) transplantation (UCBT). In utero, exposure to noninherited maternal antigen (NIMA) is recognized by the fetus, which induces T regulator cells to that haplotype. It is plausible that UCBTs in which recipients are matched to donor NIMAs may alleviate some of the excess mortality associated with this treatment. To explore this concept, we used marginal matched-pair Cox regression analysis to compare outcomes in 48 NIMA-matched UCBTs (ie, the NIMA of the donor UCB unit matched to the patient) and in 116 non–NIMA-matched UCBTs. All patients had a hematologic malignancy and received a single UCB unit. Cases and controls were matched on age, disease, disease status, transplantation-conditioning regimen, HLA match, and infused cell dose. TRM was lower after NIMA-matched UCBTs compared with NIMA-mismatched UCBTs (relative risk, 0.48; P = .05; 18% versus 32% at 5 years posttransplantation). Consequently, overall survival was higher after NIMA-matched UCBT. The 5-year probability of overall survival was 55% after NIMA-matched UCBTs versus 38% after NIMA-mismatched UCBTs (P = .04). When faced with the choice of multiple HLA-mismatched UCB units containing adequate cell doses, selecting an NIMA-matched UCB unit may improve survival after mismatched UCBT. Transplantation-related mortality (TRM) is high after HLA-mismatched umbilical cord blood (UCB) transplantation (UCBT). In utero, exposure to noninherited maternal antigen (NIMA) is recognized by the fetus, which induces T regulator cells to that haplotype. It is plausible that UCBTs in which recipients are matched to donor NIMAs may alleviate some of the excess mortality associated with this treatment. To explore this concept, we used marginal matched-pair Cox regression analysis to compare outcomes in 48 NIMA-matched UCBTs (ie, the NIMA of the donor UCB unit matched to the patient) and in 116 non–NIMA-matched UCBTs. All patients had a hematologic malignancy and received a single UCB unit. Cases and controls were matched on age, disease, disease status, transplantation-conditioning regimen, HLA match, and infused cell dose. TRM was lower after NIMA-matched UCBTs compared with NIMA-mismatched UCBTs (relative risk, 0.48; P = .05; 18% versus 32% at 5 years posttransplantation). Consequently, overall survival was higher after NIMA-matched UCBT. The 5-year probability of overall survival was 55% after NIMA-matched UCBTs versus 38% after NIMA-mismatched UCBTs (P = .04). When faced with the choice of multiple HLA-mismatched UCB units containing adequate cell doses, selecting an NIMA-matched UCB unit may improve survival after mismatched UCBT." @default.
• W2046455110 created "2016-06-24" @default.
• W2046455110 creator A5001645001 @default.
• W2046455110 creator A5005086749 @default.
• W2046455110 creator A5007202804 @default.
• W2046455110 creator A5012796837 @default.
• W2046455110 creator A5012936889 @default.
• W2046455110 creator A5023700544 @default.
• W2046455110 creator A5024526138 @default.
• W2046455110 creator A5029688759 @default.
• W2046455110 creator A5033653886 @default.
• W2046455110 creator A5041346359 @default.
• W2046455110 creator A5041864669 @default.
• W2046455110 creator A5049735878 @default.
• W2046455110 creator A5051435935 @default.
• W2046455110 creator A5053760024 @default.
• W2046455110 creator A5054532615 @default.
• W2046455110 creator A5058925624 @default.
• W2046455110 creator A5060384074 @default.
• W2046455110 creator A5064818358 @default.
• W2046455110 creator A5065110305 @default.
• W2046455110 creator A5066032215 @default.
• W2046455110 creator A5069149045 @default.
• W2046455110 creator A5073811838 @default.
• W2046455110 creator A5080362489 @default.
• W2046455110 creator A5090247028 @default.
• W2046455110 creator A5091433944 @default.
• W2046455110 date "2012-12-01" @default.
• W2046455110 modified "2023-10-17" @default.
• W2046455110 title "Effect of HLA-Matching Recipients to Donor Noninherited Maternal Antigens on Outcomes after Mismatched Umbilical Cord Blood Transplantation for Hematologic Malignancy" @default.
• W2046455110 cites W1521169335 @default.
• W2046455110 cites W1845701168 @default.
• W2046455110 cites W1976289976 @default.
• W2046455110 cites W2008928916 @default.
• W2046455110 cites W2024234239 @default.
• W2046455110 cites W2028860972 @default.
• W2046455110 cites W2033654955 @default.
• W2046455110 cites W2041965142 @default.
• W2046455110 cites W2044762933 @default.
• W2046455110 cites W2061069485 @default.
• W2046455110 cites W2072066004 @default.
• W2046455110 cites W2073696038 @default.
• W2046455110 cites W2078916311 @default.
• W2046455110 cites W2086101504 @default.
• W2046455110 cites W2099847697 @default.
• W2046455110 cites W2110475255 @default.
• W2046455110 cites W2123365414 @default.
• W2046455110 cites W2130663466 @default.
• W2046455110 cites W2134823742 @default.
• W2046455110 cites W2141557403 @default.
• W2046455110 cites W2149176302 @default.
• W2046455110 cites W2165480626 @default.
• W2046455110 doi "https://doi.org/10.1016/j.bbmt.2012.07.010" @default.
• W2046455110 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3826155" @default.
• W2046455110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22814031" @default.
• W2046455110 hasPublicationYear "2012" @default.
• W2046455110 type Work @default.
• W2046455110 sameAs 2046455110 @default.
• W2046455110 citedByCount "68" @default.
• W2046455110 countsByYear W20464551102012 @default.
• W2046455110 countsByYear W20464551102013 @default.
• W2046455110 countsByYear W20464551102014 @default.
• W2046455110 countsByYear W20464551102015 @default.
• W2046455110 countsByYear W20464551102016 @default.
• W2046455110 countsByYear W20464551102017 @default.
• W2046455110 countsByYear W20464551102018 @default.
• W2046455110 countsByYear W20464551102019 @default.
• W2046455110 countsByYear W20464551102020 @default.
• W2046455110 countsByYear W20464551102021 @default.
• W2046455110 countsByYear W20464551102022 @default.
• W2046455110 crossrefType "journal-article" @default.
• W2046455110 hasAuthorship W2046455110A5001645001 @default.
• W2046455110 hasAuthorship W2046455110A5005086749 @default.
• W2046455110 hasAuthorship W2046455110A5007202804 @default.
• W2046455110 hasAuthorship W2046455110A5012796837 @default.
• W2046455110 hasAuthorship W2046455110A5012936889 @default.
• W2046455110 hasAuthorship W2046455110A5023700544 @default.
• W2046455110 hasAuthorship W2046455110A5024526138 @default.
• W2046455110 hasAuthorship W2046455110A5029688759 @default.
• W2046455110 hasAuthorship W2046455110A5033653886 @default.
• W2046455110 hasAuthorship W2046455110A5041346359 @default.
• W2046455110 hasAuthorship W2046455110A5041864669 @default.
• W2046455110 hasAuthorship W2046455110A5049735878 @default.
• W2046455110 hasAuthorship W2046455110A5051435935 @default.
• W2046455110 hasAuthorship W2046455110A5053760024 @default.
• W2046455110 hasAuthorship W2046455110A5054532615 @default.
• W2046455110 hasAuthorship W2046455110A5058925624 @default.
• W2046455110 hasAuthorship W2046455110A5060384074 @default.
• W2046455110 hasAuthorship W2046455110A5064818358 @default.
• W2046455110 hasAuthorship W2046455110A5065110305 @default.
• W2046455110 hasAuthorship W2046455110A5066032215 @default.
• W2046455110 hasAuthorship W2046455110A5069149045 @default.
• W2046455110 hasAuthorship W2046455110A5073811838 @default.
• W2046455110 hasAuthorship W2046455110A5080362489 @default.
• W2046455110 hasAuthorship W2046455110A5090247028 @default.
• W2046455110 hasAuthorship W2046455110A5091433944 @default.
• W2046455110 hasBestOaLocation W20464551101 @default.
• W2046455110 hasConcept C126322002 @default.

• next